G-CON Manufacturing, the leading US-based provider of POD ® ...

Through its acquisition of G-CON, Summa Equity enters the rapidly growing biopharmaceutical manufacturing market, including cell and gene therapy manufacturing.(PRWeb July 20, 2021)Read the full story at https://www.prweb.com/releases/g_con_manufacturing_the_leading_us_based_provider_of_pod_cleanroom_solutions_is_acquired_by_summa_equity/prweb18080487.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news